PQJS380

References

• Pui C-H, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998; 339:605 - 15; http://dx.doi.org/10.1056/NEJM199808273390907; PMID: 9718381
   PubMed Web of Science ®Google Scholar
• Gilliland DG, Tallman MS. Focus on acute leukemias. Cancer Cell 2002; 1:417 - 20; http://dx.doi.org/10.1016/S1535-6108(02)00081-8; PMID: 12124171
   PubMed Web of Science ®Google Scholar
• Loh ML, Rubnitz JE. TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches. Curr Opin Hematol 2002; 9:345 - 52; http://dx.doi.org/10.1097/00062752-200207000-00013; PMID: 12042710
   PubMed Web of Science ®Google Scholar
• Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2002; 2:502 - 13; http://dx.doi.org/10.1038/nrc840; PMID: 12094236
   PubMed Web of Science ®Google Scholar
• Ferrando AA, Look AT. Gene expression profiling in T-cell acute lymphoblastic leukemia. Semin Hematol 2003; 40:274 - 80; http://dx.doi.org/10.1016/S0037-1963(03)00195-1; PMID: 14582078
   PubMed Web of Science ®Google Scholar
• Ayton PM, Cleary ML. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 2001; 20:5695 - 707; http://dx.doi.org/10.1038/sj.onc.1204639; PMID: 11607819
   PubMed Web of Science ®Google Scholar
• Ernst P, Wang J, Korsmeyer SJ. The role of MLL in hematopoiesis and leukemia. Curr Opin Hematol 2002; 9:282 - 7; http://dx.doi.org/10.1097/00062752-200207000-00004; PMID: 12042701
   PubMed Web of Science ®Google Scholar
• Ayton PM, Cleary ML. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 2003; 17:2298 - 307; http://dx.doi.org/10.1101/gad.1111603; PMID: 12952893
   PubMed Web of Science ®Google Scholar
• Pui C-H, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008; 371:1030 - 43; http://dx.doi.org/10.1016/S0140-6736(08)60457-2; PMID: 18358930
   PubMed Web of Science ®Google Scholar
• Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol 2009; 144:147 - 56; http://dx.doi.org/10.1111/j.1365-2141.2008.07417.x; PMID: 19006567
   PubMed Web of Science ®Google Scholar
• Schrappe M, Reiter A, Ludwig W-D, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, et al, German-Austrian-Swiss ALL-BFM Study Group. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood 2000; 95:3310 - 22; PMID: 10828010
   PubMed Web of Science ®Google Scholar
• Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 2001; 97:1211 - 8; http://dx.doi.org/10.1182/blood.V97.5.1211; PMID: 11222362
   PubMed Web of Science ®Google Scholar
• Linker C, Damon L, Ries C, Navarro W. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol 2002; 20:2464 - 71; http://dx.doi.org/10.1200/JCO.2002.07.116; PMID: 12011123
   PubMed Web of Science ®Google Scholar
• Pui C-H, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006; 354:166 - 78; http://dx.doi.org/10.1056/NEJMra052603; PMID: 16407512
   PubMed Web of Science ®Google Scholar
• van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002; 111:241 - 50; http://dx.doi.org/10.1016/S0092-8674(02)01014-0; PMID: 12408868
   PubMed Web of Science ®Google Scholar
• Gartel AL, Shchors K. Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes. Exp Cell Res 2003; 283:17 - 21; http://dx.doi.org/10.1016/S0014-4827(02)00020-4; PMID: 12565816
   PubMed Web of Science ®Google Scholar
• Wu S, Cetinkaya C, Munoz-Alonso MJ, von der Lehr N, Bahram F, Beuger V, Eilers M, Leon J, Larsson LG. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene 2003; 22:351 - 60; http://dx.doi.org/10.1038/sj.onc.1206145; PMID: 12545156
   PubMed Web of Science ®Google Scholar
• Si J, Yu X, Zhang Y, DeWille JW. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression. Mol Cancer 2010; 9:92; http://dx.doi.org/10.1186/1476-4598-9-92; PMID: 20426839
   PubMed Web of Science ®Google Scholar
• Yan W, Samson M, Jégou B, Toppari J. Bcl-w forms complexes with Bax and Bak, and elevated ratios of Bax/Bcl-w and Bak/Bcl-w correspond to spermatogonial and spermatocyte apoptosis in the testis. Mol Endocrinol 2000; 14:682 - 99; http://dx.doi.org/10.1210/me.14.5.682; PMID: 10809232
   PubMed Web of Science ®Google Scholar
• Weber A, Paschen SA, Heger K, Wilfling F, Frankenberg T, Bauerschmitt H, Seiffert BM, Kirschnek S, Wagner H, Häcker G. BimS-induced apoptosis requires mitochondrial localization but not interaction with anti-apoptotic Bcl-2 proteins. J Cell Biol 2007; 177:625 - 36; http://dx.doi.org/10.1083/jcb.200610148; PMID: 17517961
   PubMed Web of Science ®Google Scholar
• Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9:47 - 59; http://dx.doi.org/10.1038/nrm2308; PMID: 18097445
   PubMed Web of Science ®Google Scholar
• Garbe C, Leiter U. Melanoma epidemiology and trends. Clin Dermatol 2009; 27:3 - 9; http://dx.doi.org/10.1016/j.clindermatol.2008.09.001; PMID: 19095149
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
   PubMed Web of Science ®Google Scholar
• Zhang LN, Li JY, Xu W. A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia. Cancer Gene Ther 2013; 20:1 - 7; http://dx.doi.org/10.1038/cgt.2012.84; PMID: 23175245
   PubMed Web of Science ®Google Scholar
• Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T, Korsmeyer SJ. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001; 8:705 - 11; http://dx.doi.org/10.1016/S1097-2765(01)00320-3; PMID: 11583631
   PubMed Web of Science ®Google Scholar
• Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001; 292:727 - 30; http://dx.doi.org/10.1126/science.1059108; PMID: 11326099
   PubMed Web of Science ®Google Scholar
• Kitada S, Pedersen IM, Schimmer AD, Reed JC. Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene 2002; 21:3459 - 74; http://dx.doi.org/10.1038/sj.onc.1205327; PMID: 12032782
   PubMed Web of Science ®Google Scholar
• Mounier N, Briere J, Gisselbrecht C, Emile JF, Lederlin P, Sebban C, Berger F, Bosly A, Morel P, Tilly H, et al. Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). Blood 2003; 101:4279 - 84; http://dx.doi.org/10.1182/blood-2002-11-3442; PMID: 12576316
   PubMed Web of Science ®Google Scholar
• Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005; 435:677 - 81; http://dx.doi.org/10.1038/nature03579; PMID: 15902208
   PubMed Web of Science ®Google Scholar
• Aichberger KJ, Mayerhofer M, Gleixner KV, Krauth MT, Gruze A, Pickl WF, Wacheck V, Selzer E, Müllauer L, Agis H, et al. Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412. Blood 2007; 109:3031 - 41; PMID: 17110460
   PubMed Web of Science ®Google Scholar
• Kang SY, Han JH, Lee KJ, Choi JH, Park JI, Kim HI, Lee HW, Jang JH, Park JS, Kim HC, et al. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. Clin Cancer Res 2007; 13:4146 - 53; http://dx.doi.org/10.1158/1078-0432.CCR-06-3063; PMID: 17634542
   PubMed Web of Science ®Google Scholar
• Jeong SH, Lee HW, Han JH, Kang SY, Choi JH, Jung YM, Choi H, Oh YT, Park KJ, Hwang SC, et al. Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology. Jpn J Clin Oncol 2008; 38:661 - 9; http://dx.doi.org/10.1093/jjco/hyn089; PMID: 18772168
   PubMed Web of Science ®Google Scholar
• Byun JY, Kim MJ, Eum DY, Yoon CH, Seo WD, Park KH, Hyun JW, Lee YS, Lee JS, Yoon MY, et al. Reactive oxygen species-dependent activation of Bax and poly(ADP-ribose) polymerase-1 is required for mitochondrial cell death induced by triterpenoid pristimerin in human cervical cancer cells. Mol Pharmacol 2009; 76:734 - 44; http://dx.doi.org/10.1124/mol.109.056259; PMID: 19574249
   PubMed Web of Science ®Google Scholar
• Prokop A, Wieder T, Sturm I, Essmann F, Seeger K, Wuchter C, Ludwig WD, Henze G, Dörken B, Daniel PT. Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo. Leukemia 2000; 14:1606 - 13; http://dx.doi.org/10.1038/sj.leu.2401866; PMID: 10995007
   PubMed Web of Science ®Google Scholar
• Troeger A, Siepermann M, Escherich G, Meisel R, Willers R, Gudowius S, Moritz T, Laws HJ, Hanenberg H, Goebel U, et al. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia. Haematologica 2007; 92:1043 - 50; http://dx.doi.org/10.3324/haematol.10675; PMID: 17640858
   PubMed Web of Science ®Google Scholar
• Vogler M, Giagkousiklidis S, Genze F, Gschwend JE, Debatin KM, Fulda S. Inhibition of clonogenic tumor growth: a novel function of Smac contributing to its antitumor activity. Oncogene 2005; 24:7190 - 202; http://dx.doi.org/10.1038/sj.onc.1208876; PMID: 16091752
   PubMed Web of Science ®Google Scholar
• Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation. Clin Cancer Res 2009; 15:1686 - 97; http://dx.doi.org/10.1158/1078-0432.CCR-08-2141; PMID: 19240172
   PubMed Web of Science ®Google Scholar
• Pan J, Quintás-Cardama A, Kantarjian HM, Akin C, Manshouri T, Lamb P, Cortes JE, Tefferi A, Giles FJ, Verstovsek S. EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation. Blood 2007; 109:315 - 22; http://dx.doi.org/10.1182/blood-2006-04-013805; PMID: 16912224
   PubMed Web of Science ®Google Scholar
• Jin Y, Chen Q, Shi X, Lu Z, Cheng C, Lai Y, Zheng Q, Pan J. Activity of triptolide against human mast cells harboring the kinase domain mutant KIT. Cancer Sci 2009; 100:1335 - 43; http://dx.doi.org/10.1111/j.1349-7006.2009.01159.x; PMID: 19383029
   PubMed Web of Science ®Google Scholar
• Gotlib J, Berubé C, Growney JD, Chen CC, George TI, Williams C, Kajiguchi T, Ruan J, Lilleberg SL, Durocher JA, et al. Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 2005; 106:2865 - 70; http://dx.doi.org/10.1182/blood-2005-04-1568; PMID: 15972446
   PubMed Web of Science ®Google Scholar